Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-24

Clinical Trial Update: A German Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Type 2 Diabetes Patients. [NA]

View source ↗

Summary

A completed German clinical study assessing the efficacy and benefits of Integrated Personalized Diabetes Management (PDM) for adults with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus, Type 2 | NA | Status: COMPLETED